Cost-effectiveness Analysis of Anlotinib Plus Chemotherapy with or Without Benmelstobart Versus Chemotherapy Alone for Extensive-Stage Small-Cell Lung Cancer in China

Caicong You, Jiahao Zhang, Jianying Lei, Wu Fu,Bin Zheng,Maobai Liu, Na Li

FRONTIERS IN ONCOLOGY（2024）

引用 0|浏览1

关键词

cost-effectiveness,benmelstobart,anlotinib,extensive-stage small-cell lung,scenario analysis,R software,time-varying Markov

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要